85 related articles for article (PubMed ID: 21093437)
1. Potassium channel blocker, 4-aminopyridine-3-methanol, restores axonal conduction in spinal cord of an animal model of multiple sclerosis.
Leung G; Sun W; Brookes S; Smith D; Shi R
Exp Neurol; 2011 Jan; 227(1):232-5. PubMed ID: 21093437
[TBL] [Abstract][Full Text] [Related]
2. Acute axon damage and demyelination are mitigated by 4-aminopyridine (4-AP) therapy after experimental traumatic brain injury.
Radomski KL; Zi X; Lischka FW; Noble MD; Galdzicki Z; Armstrong RC
Acta Neuropathol Commun; 2022 May; 10(1):67. PubMed ID: 35501931
[TBL] [Abstract][Full Text] [Related]
3. 4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury.
Tseng KC; Li H; Clark A; Sundem L; Zuscik M; Noble M; Elfar J
EMBO Mol Med; 2016 Dec; 8(12):1409-1420. PubMed ID: 27861125
[TBL] [Abstract][Full Text] [Related]
4. Chemical and biophysical characterization of novel potassium channel blocker 3-fluoro-5-methylpyridin-4-amine.
Sun Y; Rodríguez-Rangel S; Zhang LL; Sánchez-Rodríguez JE; Brugarolas P
Sci Rep; 2024 May; 14(1):11105. PubMed ID: 38750155
[TBL] [Abstract][Full Text] [Related]
5. Chemical and biophysical characterization of novel potassium channel blocker 3-fluoro-5-methylpyridin-4-amine.
Sun Y; Rodríguez-Rangel S; Zhang LL; Sánchez-Rodríguez JE; Brugarolas P
bioRxiv; 2023 Aug; ():. PubMed ID: 37609160
[TBL] [Abstract][Full Text] [Related]
6. Imaging demyelinated axons after spinal cord injuries with PET tracer [
Ramos-Torres KM; Conti S; Zhou YP; Tiss A; Caravagna C; Takahashi K; He M; Wilks MQ; Eckl S; Sun Y; Biundo J; Gong K; He Z; Linnman C; Brugarolas P
bioRxiv; 2024 May; ():. PubMed ID: 38712041
[TBL] [Abstract][Full Text] [Related]
7. 4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review.
Jensen HB; Ravnborg M; Dalgas U; Stenager E
Ther Adv Neurol Disord; 2014 Mar; 7(2):97-113. PubMed ID: 24587826
[TBL] [Abstract][Full Text] [Related]
8. 4-Aminopyridine Induces Nerve Growth Factor to Improve Skin Wound Healing and Tissue Regeneration.
Jagadeeshaprasad MG; Govindappa PK; Nelson AM; Noble MD; Elfar JC
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884953
[TBL] [Abstract][Full Text] [Related]
9. Aminopyridines for the treatment of neurologic disorders.
Strupp M; Teufel J; Zwergal A; Schniepp R; Khodakhah K; Feil K
Neurol Clin Pract; 2017 Feb; 7(1):65-76. PubMed ID: 28243504
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection by acrolein sequestration through exogenously applied scavengers and endogenous enzymatic enabling strategies in mouse EAE model.
Tang J; Alford A; Leung G; Tully M; Shi R
Sci Rep; 2024 Mar; 14(1):6027. PubMed ID: 38472318
[TBL] [Abstract][Full Text] [Related]
11. The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity.
Provenzano F; Torazza C; Bonifacino T; Bonanno G; Milanese M
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895110
[TBL] [Abstract][Full Text] [Related]
12. Remote but not Distant: a Review on Experimental Models and Clinical Trials in Remote Ischemic Conditioning as Potential Therapy in Ischemic Stroke.
Mollet I; Marto JP; Mendonça M; Baptista MV; Vieira HLA
Mol Neurobiol; 2022 Jan; 59(1):294-325. PubMed ID: 34686988
[TBL] [Abstract][Full Text] [Related]
13. 4-Aminopyridine: A Single-Dose Diagnostic Agent to Differentiate Axonal Continuity in Nerve Injuries.
Gurjar AA; Manto KM; Estrada JA; Kaufman M; Sun D; Talukder MAH; Elfar JC
Mil Med; 2021 Jan; 186(Suppl 1):479-485. PubMed ID: 33499448
[TBL] [Abstract][Full Text] [Related]
14. 4-AP-3-MeOH Promotes Structural and Functional Spontaneous Recovery in the Acute Sciatic Nerve Stretch Injury.
Chen Y; Wang W; Zhao Z; Ren D; Xin D
Dose Response; 2020; 18(1):1559325819899254. PubMed ID: 32009855
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship studies of four novel 4-aminopyridine K
Rodríguez-Rangel S; Bravin AD; Ramos-Torres KM; Brugarolas P; Sánchez-Rodríguez JE
Sci Rep; 2020 Jan; 10(1):52. PubMed ID: 31919372
[TBL] [Abstract][Full Text] [Related]
16. Development of a PET radioligand for potassium channels to image CNS demyelination.
Brugarolas P; Sánchez-Rodríguez JE; Tsai HM; Basuli F; Cheng SH; Zhang X; Caprariello AV; Lacroix JJ; Freifelder R; Murali D; DeJesus O; Miller RH; Swenson RE; Chen CT; Herscovitch P; Reich DS; Bezanilla F; Popko B
Sci Rep; 2018 Jan; 8(1):607. PubMed ID: 29330383
[TBL] [Abstract][Full Text] [Related]
17. Parallel Evaluation of Two Potassium Channel Blockers in Restoring Conduction in Mechanical Spinal Cord Injury in Rat.
Page JC; Park J; Chen Z; Cao P; Shi R
J Neurotrauma; 2018 May; 35(9):1057-1068. PubMed ID: 29228863
[TBL] [Abstract][Full Text] [Related]
18. The effects of paranodal myelin damage on action potential depend on axonal structure.
Daneshi Kohan E; Lashkari BS; Sparrey CJ
Med Biol Eng Comput; 2018 Mar; 56(3):395-411. PubMed ID: 28770425
[TBL] [Abstract][Full Text] [Related]
19. T-lymphocyte K
Zhu J; Yang Y; Hu SG; Zhang QB; Yu J; Zhang YM
Exp Ther Med; 2017 Jul; 14(1):147-154. PubMed ID: 28672906
[TBL] [Abstract][Full Text] [Related]
20. Elevated axonal membrane permeability and its correlation with motor deficits in an animal model of multiple sclerosis.
Leung G; Tully M; Tang J; Wu S; Shi R
Transl Neurodegener; 2017; 6():5. PubMed ID: 28265351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
